PRAX - Praxis Precision Medicines GAAP EPS of -$0.18 beats by $0.17 revenue of $0.47M
2023-11-07 08:24:33 ET
More on Praxis Precision Medicines
- Praxis, Ionis stocks dip in wake of Praxis drug updates
- Praxis Precision Meds up 9% on new Truist buy rating
- Seeking Alpha’s Quant Rating on Praxis Precision Medicines
For further details see:
Praxis Precision Medicines GAAP EPS of -$0.18 beats by $0.17, revenue of $0.47M